Low-dose Interleukin-2 Treatment for Autism in Children
Treatments studied
Part of Mental health clinical trials.
This study tests whether a low dose of interleukin-2 (a protein that helps the immune system) might improve symptoms in children with moderate to severe autism. The research is based on the idea that some autism may be linked to immune system issues, especially when the mother had an autoimmune disease or infection during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is between 6 and 8 years old
- Your child has been diagnosed with autism spectrum disorder (ASD) that is moderate or severe
- Your child's mother had an autoimmune disease that started or got worse during pregnancy, OR had a documented fever-causing infection during pregnancy
- Your child has not started new autism treatments (like therapy or medications) in the last 2–6 weeks
- Your child is generally healthy and has no history of cancer, active infections, or recent live vaccines
- Your family lives in the Paris hospital intervention area and can participate in the study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study combines three treatments—light therapy at acupoints, your child's own platelet-rich plasma, and umbilical cord exosomes—to see if they can help improve symptoms of autism spectrum disorder. It's for children ages 3 to 12 with an autism diagnosis, and you'll work closely with the study team.
This study tests an experimental medication called TB006 for adults with autism. It aims to see if it can help reduce symptoms. Participants must be 18–35, have moderate-to-severe autism, and have a caregiver who can join them.
This study tests a combination of experimental treatments for children with autism spectrum disorder. It may help if your child has not had stem cell or glutathione therapy before.
This trial tests if the steroid prednisone can help adults with moderate-to-severe autism who also have signs of immune system problems, like autoimmune disease or inflammation. It might offer a new treatment option for people whose autism is linked to immune activity.
This is an early-stage study exploring a new experimental treatment for autism spectrum disorder (ASD). Researchers will work with your child and family to test whether this approach is safe and how it might help with autism symptoms.
This study tests whether an antioxidant supplement (something that fights cell damage) can help children with autism. It lasts 3 months and requires that the child stays on their current treatments without changes.
Hear when a new Autism spectrum disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.